Suven Life Sciences - Quaterly Results

30 Jan 2026 Evaluate
The turnover soared 74.47% to Rs. 28.09 millions for the December 2025 quarter as compared to Rs. 16.10 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2025 is Rs. -134.71 millions as compared to Net Loss of Rs. -132.73 millions of corresponding quarter ended December 2024 Operating profit Margin for the quarter ended December 2025 further decreased to -121.25% as compared to -117.31% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 28.09 16.10 74.47 55.95 51.89 7.82 66.56 116.93 -43.08
Other Income 27.66 15.69 76.29 71.33 95.35 -25.19 107.26 211.30 -49.24
PBIDT -121.25 -117.31 3.36 -396.63 -274.89 44.29 -412.11 -98.07 320.22
Interest 0.00 0.08 0.00 0.00 0.47 0.00 0.47 1.58 -70.25
PBDT -121.25 -117.39 3.29 -396.63 -275.36 44.04 -412.58 -25.08 1545.06
Depreciation 13.46 15.34 -12.26 40.31 44.75 -9.92 58.22 65.02 -10.46
PBT -134.71 -132.73 1.49 -436.94 -320.11 36.50 -470.80 -90.10 422.53
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -10.02 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -134.71 -132.73 1.49 -436.94 -320.11 36.50 -470.80 -80.08 487.91
Equity 227.47 218.07 4.31 227.47 218.07 4.31 218.07 218.07 0.00
PBIDTM(%) -431.65 -728.63 -40.76 -708.90 -529.76 33.82 -619.16 -83.87 638.23

Suven Life Sciences Share Price

132.80 1.80 (1.37%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×